Literature DB >> 23510220

Teratogenic and toxic effects of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W.Curt.:Fr.) P. Karst. (higher Basidiomycetes), on zebrafish embryo as model.

Rich Milton R Dulay1, Sofronio P Kalaw, Renato G Reyes, Noel F Alfonso, Fumio Eguchi.   

Abstract

This paper highlights the teratogenic and toxic effects of Ganoderma lucidum (Lingzhi or Reishi mushroom) extract on zebrafish embryos. Hatchability, malformations, and lethality rate of zebrafish embryos were assessed to provide valuable information regarding the potential teratogenic activity of G. lucidum. Hatching was completed 48 h post treatment application (hpta) at 1% or lower concentrations of extract and embryo water. The hatching rate of embryos treated with 5% or higher concentrations was significantly lower (p> 0.05) than the control. Tail malformation was the most marked morphological abnormality in embryos at 72 hpta, which was obviously caused by 1% extract (55.56% tail malformation) and was observed in all embryos exposed to 5% of extract. Growth retardation was evident in embryos exposed to 5%, 10%, and 20%. However, lethal effect of extract of G. lucidum was dependent on dose and time of exposure. Mortality rates of embryos treated with 5% (44.44%) or higher concentrations of the extract was significantly higher (p > 0.05) than that of the control embryos at 72 hpta. These results suggest that G. lucidum extract has lethal and sub-lethal effects on zebrafish embryos.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23510220     DOI: 10.1615/intjmedmushr.v14.i5.90

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  3 in total

1.  Use of Zebrafish Embryo Assay to Evaluate Toxicity and Safety of Bioreactor-Grown Exopolysaccharides and Endopolysaccharides from European Ganoderma applanatum Mycelium for Future Aquaculture Applications.

Authors:  Wan Abd Al Qadr Imad Wan-Mohtar; Zul Ilham; Adi Ainurzaman Jamaludin; Neil Rowan
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

2.  Bioreactor-grown exo- and endo-β-glucan from Malaysian Ganoderma lucidum: An in vitro and in vivo study for potential antidiabetic treatment.

Authors:  Nur Raihan Abdullah; Mohd Hamzah Mohd Nasir; Nur Hafizah Azizan; Wan Abd Al Qadr Imad Wan-Mohtar; Faez Sharif
Journal:  Front Bioeng Biotechnol       Date:  2022-08-25

3.  Antitumor Activity of Extract From the Sporoderm-Breaking Spore of Ganoderma lucidum: Restoration on Exhausted Cytotoxic T Cell With Gut Microbiota Remodeling.

Authors:  Jiyan Su; Lu Su; Dan Li; Ou Shuai; Yifan Zhang; Huijia Liang; Chunwei Jiao; Zhanchi Xu; Yong Lai; Yizhen Xie
Journal:  Front Immunol       Date:  2018-07-31       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.